To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene BCAR1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
375 representative clones for gene BCAR1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK314722 thalamus .a 1 to 2759 1 to 2759 P124S Q199L G902D tiling clone,   2759/2759
(100 %)
4 diff
(99.9 %id)
NM_014567.3   .a 1 to 3239 1 to 3239 exact RefSeq, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 3239/3239
(100 %)
0 diff
(100 %id)
AB040024   .a 20 to 3233 15 to 3228   tiling clone,   3214/3228
(99 %)
8 diff
(99.8 %id)
AF218451 testis .a 23 to 3177 1 to 3155   tiling clone, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 3155/3155
(100 %)
9 diff
(99.8 %id)
AJ242987 breast .a 24 to 3235 1 to 3208   tiling clone,   3208/3208
(100 %)
5 diff
(99.9 %id)
BC062556 Lung, epidermoid carcinoma .a 146 to 3233 1 to 3088   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 3088/3088
(100 %)
4 diff
(99.9 %id)
DA582188 lung .b 1 to 440 2 to 442   tiling clone, capped   441/441
(100 %)
5 diff
(98.9 %id)
AK293808 cerebellum .b 355 to 3741 1 to 3387 P122S tiling clone,   3387/3387
(100 %)
4 diff
(99.9 %id)
DC307421 cerebellum .b 355 to 894 1 to 541       541/541
(100 %)
1 diff
(99.9 %id)
NM_001170714.1   .b 355 to 3869 1 to 3515 exact RefSeq, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 3515/3515
(100 %)
0 diff
(100 %id)
CN348287 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1 to 294 1 to 296   tiling clone,   296/296
(100 %)
3 diff
(99.0 %id)
CN348290 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 25 to 380 1 to 357       357/357
(100 %)
4 diff
(98.9 %id)
NM_001170717.1   .c 30 to 3322 1 to 3293 exact RefSeq, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 3293/3293
(100 %)
0 diff
(100 %id)
DA418642 thalamus .c 31 to 437 2 to 408   tiling clone, capped   407/407
(100 %)
1 diff
(99.8 %id)
CN348296 embryonic stem cells, cell lines H1, H7, andH9 .c 33 to 183 1 to 152       152/152
(100 %)
2 diff
(98.7 %id)
DA737254   .c 35 to 739 2 to 708   capped   707/774
(91 %)
7 diff
(99.1 %id)
DN999556   .c 39 to 584 7 to 552       546/552
(98 %)
7 diff
(98.8 %id)
CN348286 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 45 to 542 1 to 498       498/498
(100 %)
7 diff
(98.6 %id)
CN348291 embryonic stem cells, cell lines H1, H7, andH9 .c 48 to 727 1 to 680       680/680
(100 %)
1 diff
(99.9 %id)
AL040801 testis .c 49 to 760 17 to 728       712/728
(97 %)
7 diff
(99.1 %id)
DB084145 testis .c 60 to 618 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
BI830746 brain, medulla .c 66 to 725 1 to 708       708/992
(71 %)
65 diff
(93.5 %id)
CN348297 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 70 to 616 1 to 547       547/547
(100 %)
8 diff
(98.6 %id)
DB055538 testis .c 144 to 711 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
BG037188 testis .c 155 to 814 1 to 655       655/723
(90 %)
21 diff
(97.1 %id)
AY545071   .c 176 to 2842 1 to 2667 T403A N618S D758G tiling clone,   2667/2667
(100 %)
5 diff
(99.9 %id)
BF980015 testis .c 2651 to 3242 601 to 3   tiling clone,   599/651
(92 %)
0 diff
(100 %id)
DB369843   .c 2755 to 3316 565 to 1   tiling clone,   565/565
(100 %)
12 diff
(97.9 %id)
AL040802 testis .c 2852 to 3307 456 to 1   tiling clone,   456/456
(100 %)
1 diff
(99.8 %id)
DC317704 amygdala .d 1 to 334 1 to 334   tiling clone,   334/334
(100 %)
1 diff
(99.8 %id)
DC317947 amygdala .d 80 to 666 1 to 587       587/587
(100 %)
2 diff
(99.7 %id)
NM_001170716.1   .d 83 to 3259 1 to 3177 exact RefSeq, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 3177/3177
(100 %)
0 diff
(100 %id)
AK295809 hippocampus .d 111 to 2835 1 to 2725 exact tiling clone,   2725/2725
(100 %)
2 diff
(100.0 %id)
DC335258 hippocampus .d 111 to 685 1 to 575       575/575
(100 %)
0 diff
(100 %id)
AK124815 caudate nucleus .e 1 to 3210 2 to 3211 V272I P732L tiling clone, available from FLJ,   3211/3211
(100 %)
9 diff
(99.8 %id)
DA263808 caudate nucleus .e 1 to 565 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
NM_001170715.1   .e 3 to 3222 1 to 3220 exact RefSeq, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 3220/3220
(100 %)
0 diff
(100 %id)
DA954267 Spleen .e 48 to 640 2 to 594   capped   593/593
(100 %)
2 diff
(99.7 %id)
BQ939812 epidermoid carcinoma, cell line, lung .e 138 to 922 8 to 796       790/904
(87 %)
15 diff
(98.4 %id)
DB007793 cervix, tumor tissue .e 203 to 765 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
CX757533 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 204 to 886 1 to 683       683/683
(100 %)
0 diff
(100 %id)
BQ425113 melanotic melanoma, skin .e 217 to 1042 36 to 867       832/888
(93 %)
22 diff
(97.6 %id)
DA507365 brain .e 267 to 830 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB160886 thymus .e 312 to 890 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA049245   .e 316 to 923 2 to 609   capped   608/608
(100 %)
3 diff
(99.6 %id)
BM781640 Ascites, stomach .e 328 to 915 1 to 590       590/590
(100 %)
3 diff
(99.5 %id)
CO404399 Chondrosarcoma Lung Metastasis cell lines, lung .e 349 to 1041 1 to 689       689/849
(81 %)
12 diff
(98.6 %id)
CO247235 Chondrosarcoma Lung Metastasis cell lines, lung .e 375 to 1032 1 to 654       654/807
(81 %)
11 diff
(98.7 %id)
DA710741   .e 405 to 903 2 to 500   capped   499/499
(100 %)
0 diff
(100 %id)
BM461632 eye, retinoblastoma .e 428 to 1328 1 to 908       908/1017
(89 %)
11 diff
(99.0 %id)
BG423897 Kidney, renal cell adenocarcinoma .e 439 to 1213 1 to 770       766/942
(81 %)
27 diff
(97.2 %id)
CD243390 testis .e 520 to 1300 29 to 819       791/965
(81 %)
20 diff
(98.0 %id)
BP203395 coronary artery .e 533 to 1114 1 to 582       582/582
(100 %)
0 diff
(100 %id)
TI_154197894   .e 543 to 1379 97 to 918       822/975
(84 %)
37 diff
(96.3 %id)
CO246603 Chondrosarcoma Lung Metastasis cell lines, lung .e 553 to 1297 3 to 754       759/754
(100 %)
7 diff
(99.1 %id)
BU501452 eye, normal pigmented retinal epithelium .e 557 to 1489 1 to 952       952/960
(99 %)
23 diff
(97.7 %id)
BQ876153 eye, normal pigmented retinal epithelium .e 557 to 1427 1 to 894       894/909
(98 %)
41 diff
(95.5 %id)
TI_154197609   .e 573 to 1372 78 to 869       792/947
(83 %)
37 diff
(96.1 %id)
AK074958   .e 574 to 3216 1 to 2643   available from FLJ,   2643/2643
(100 %)
3 diff
(99.9 %id)
DA736134   .e 575 to 1390 2 to 813   capped   812/814
(99 %)
10 diff
(98.8 %id)
DA282240 corpus callosum .e 583 to 1153 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BQ923179 eye, normal pigmented retinal epithelium .e 594 to 1406 1 to 829       829/922
(89 %)
26 diff
(97.2 %id)
TI_154195411   .e 596 to 1550 23 to 970       948/1084
(87 %)
18 diff
(98.4 %id)
TI_154186539   .e 624 to 1372 27 to 777       751/751
(100 %)
3 diff
(99.7 %id)
DB204764 trachea .e 664 to 1127 2 to 465   capped   464/464
(100 %)
0 diff
(100 %id)
DA308007 hippocampus .e 681 to 1244 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA790302 brain .e 681 to 1185 2 to 506   capped   505/505
(100 %)
0 diff
(100 %id)
DA215809 brain .e 722 to 1197 2 to 477   capped   476/476
(100 %)
0 diff
(100 %id)
DA235015 brain .e 722 to 1310 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DA769531 brain .e 722 to 1308 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
BG260802 bladder, transitional cell papilloma, cell line .e 726 to 1482 1 to 751       751/755
(99 %)
26 diff
(96.6 %id)
BM556034 duodenal adenocarcinoma, cell line, small intestine .e 744 to 1573 1 to 833       833/1041
(80 %)
31 diff
(97.1 %id)
DA287161 corpus callosum .e 750 to 1297 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA590289 lung .e 800 to 1370 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
CX164434 human embryonic stem cells differentiated toan early endodermal cell type .e 824 to 1472 1 to 649       649/649
(100 %)
0 diff
(100 %id)
TI_154197905   .e 831 to 1711 80 to 954       875/1008
(86 %)
42 diff
(95.9 %id)
DA167641 amygdala .e 873 to 1417 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA027350   .e 875 to 1417 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
CF132221 Chondrosarcoma Lung Metastasis cell lines, lung .e 887 to 1655 1 to 763   tiling clone,   763/769
(99 %)
10 diff
(98.7 %id)
TI_159678067   .e 887 to 1691 51 to 844       794/1052
(75 %)
17 diff
(98.4 %id)
BQ426082 leiomyosarcoma, uterus .e 899 to 1636 1 to 742       742/838
(88 %)
14 diff
(98.4 %id)
BG387070 adenocarcinoma cell line, colon .e 916 to 1393 1 to 478       478/478
(100 %)
0 diff
(100 %id)
CN348288 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 929 to 1522 10 to 604       595/604
(98 %)
5 diff
(99.2 %id)
CN348298 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 962 to 1561 1 to 600       600/600
(100 %)
2 diff
(99.7 %id)
BQ924957 sciatic nerve .e 1042 to 1755 16 to 735       720/1059
(67 %)
19 diff
(98.3 %id)
DA730531   .e 1047 to 1714 2 to 668   capped   667/667
(100 %)
4 diff
(99.5 %id)
DB022922 testis .e 1054 to 1616 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
CX164608 human embryonic stem cells differentiated toan early endodermal cell type .e 1061 to 1859 1 to 799       799/799
(100 %)
2 diff
(99.8 %id)
BQ427979 melanotic melanoma, skin .e 1062 to 1663 1 to 603       603/831
(72 %)
4 diff
(99.6 %id)
BM690890 eye, RPE and Choroid .e 1080 to 1751 3 to 660     Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 658/661
(99 %)
20 diff
(97.0 %id)
CD723036 eye, lacrimal gland .e 1203 to 1804 1 to 602       602/602
(100 %)
1 diff
(99.9 %id)
CD723042 eye, lacrimal gland .e 1203 to 1795 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
DB108908 thymus .e 1204 to 1786 2 to 585   tiling clone, capped   584/584
(100 %)
1 diff
(99.9 %id)
T08119   .e 1214 to 1548 1 to 335       335/335
(100 %)
0 diff
(100 %id)
BE208445 lung, small cell carcinoma .e 1256 to 1794 1 to 539       539/539
(100 %)
1 diff
(99.9 %id)
BF345964 anaplastic oligodendroglioma with 1p/19qloss, brain .e 1259 to 1968 1 to 699       699/971
(71 %)
19 diff
(98.1 %id)
BI766523 pooled lung and spleen .e 1301 to 2129 1 to 840       840/850
(98 %)
37 diff
(95.7 %id)
TI_159677890   .e 1301 to 2144 50 to 878       829/1014
(81 %)
22 diff
(97.9 %id)
CF132151 Chondrosarcoma Lung Metastasis cell lines, lung .e 1302 to 2130 1 to 814       814/814
(100 %)
16 diff
(98.1 %id)
BQ941385 large cell carcinoma, lung .e 1338 to 2229 1 to 903       903/925
(97 %)
17 diff
(98.2 %id)
BC014402 Kidney, renal cell adenocarcinoma .e 1342 to 3218 1 to 1877   available from MGC, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 1877/1878
(99 %)
3 diff
(99.9 %id)
BM051213 eye, normal pigmented retinal epithelium .e 1348 to 2092 1 to 740       740/740
(100 %)
11 diff
(98.6 %id)
BG338354 leiomyosarcoma cell line, uterus .e 1377 to 2138 1 to 765       765/765
(100 %)
24 diff
(96.9 %id)
BX372322   .e 1462 to 2394 917 to 1       917/920
(99 %)
32 diff
(96.6 %id)
CF552278 Pooled muscle (cardiac and skeletal) .e 1498 to 2365 1 to 874       874/874
(100 %)
8 diff
(99.1 %id)
AK026121   .e 1500 to 3216 1 to 1717   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 1717/1717
(100 %)
2 diff
(99.9 %id)
BM829847 stomach .e 1510 to 2117 1 to 609       609/609
(100 %)
2 diff
(99.7 %id)
BU177319 melanotic melanoma, skin .e 1521 to 2379 1 to 881       881/882
(99 %)
33 diff
(96.3 %id)
BU542607 carcinoma, cell line, Prostate .e 1599 to 2333 1 to 745       745/787
(94 %)
27 diff
(96.6 %id)
CX873133 embryonic stem .e 1655 to 2445 1 to 791       791/791
(100 %)
2 diff
(99.8 %id)
BG747126 adenocarcinoma cell line, colon .e 1694 to 2404 1 to 713       713/715
(99 %)
5 diff
(99.4 %id)
BU528147 epidermoid carcinoma, cell line, lung .e 1717 to 2615 1 to 901       901/905
(99 %)
9 diff
(99.1 %id)
CD625777   .e 1723 to 2395 1 to 670       670/670
(100 %)
3 diff
(99.6 %id)
CD625779   .e 1723 to 2452 1 to 730       730/730
(100 %)
9 diff
(98.8 %id)
BG913819 anaplastic oligodendroglioma with 1p/19qloss, brain .e 1739 to 2570 1 to 832       832/833
(99 %)
22 diff
(97.4 %id)
BF869657 lung_tumor .e 1745 to 2002 258 to 1     Submitted on the opposite strand 258/258
(100 %)
0 diff
(100 %id)
BF870054 lung_tumor .e 1745 to 2002 258 to 1     Submitted on the opposite strand 258/258
(100 %)
0 diff
(100 %id)
BU527915 epidermoid carcinoma, cell line, lung .e 1788 to 2692 1 to 907       907/907
(100 %)
12 diff
(98.7 %id)
CN401187 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 1831 to 2611 1 to 782       782/782
(100 %)
1 diff
(99.9 %id)
TI_154193244   .e 1878 to 2698 50 to 867       818/872
(93 %)
9 diff
(99.0 %id)
CF127681 Chondrosarcoma Lung Metastasis cell lines, lung .e 1879 to 2610 1 to 732       732/732
(100 %)
0 diff
(100 %id)
BF688193 eye, normal pigmented retinal epithelium .e 1912 to 2626 1 to 710       710/964
(73 %)
17 diff
(98.3 %id)
BG775027 carcinoma, cell line, Prostate .e 1930 to 2753 1 to 819       819/820
(99 %)
7 diff
(99.2 %id)
BU541175 carcinoma, cell line, Prostate .e 1939 to 2723 1 to 794       794/911
(87 %)
13 diff
(98.6 %id)
BU541498 carcinoma, cell line, Prostate .e 1939 to 2786 1 to 850       850/872
(97 %)
9 diff
(99.0 %id)
BU542520 carcinoma, cell line, Prostate .e 1939 to 2735 1 to 806       806/912
(88 %)
9 diff
(99.1 %id)
BU838220 melanotic melanoma, cell line, skin .e 1955 to 2750 1 to 800       800/802
(99 %)
5 diff
(99.4 %id)
BU194332 melanotic melanoma, cell line, skin .e 1955 to 2783 1 to 836       836/919
(90 %)
10 diff
(99.0 %id)
BQ678580 melanotic melanoma, cell line, skin .e 1955 to 2714 1 to 761       761/904
(84 %)
16 diff
(98.3 %id)
BU157529 melanotic melanoma, cell line, skin .e 1955 to 2776 1 to 837       837/987
(84 %)
24 diff
(97.6 %id)
BX114891 senescent fibroblast .e 1958 to 2611 1 to 654       654/654
(100 %)
3 diff
(99.6 %id)
CD673202 eye, Iris .e 1959 to 2465 1 to 507       507/507
(100 %)
0 diff
(100 %id)
BQ948147 eye, normal pigmented retinal epithelium .e 2006 to 2698 1 to 699       699/980
(71 %)
15 diff
(98.5 %id)
BQ688682 ductal carcinoma, cell line, Pancreas .e 2021 to 2854 1 to 842       842/854
(98 %)
14 diff
(98.4 %id)
CA488735   .e 2055 to 2851 1 to 807       807/909
(88 %)
15 diff
(98.4 %id)
BY799778 eye .e 2091 to 2626 1 to 536       536/536
(100 %)
0 diff
(100 %id)
BF345455 anaplastic oligodendroglioma with 1p/19qloss, brain .e 2115 to 3013 1 to 886       886/993
(89 %)
45 diff
(95.5 %id)
BM704395 eye, RPE and Choroid .e 2123 to 2721 1 to 599   fully sequenced, Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 599/599
(100 %)
0 diff
(100 %id)
BU527077 epidermoid carcinoma, cell line, lung .e 2124 to 3006 1 to 894       894/936
(95 %)
26 diff
(97.3 %id)
BF530395 anaplastic oligodendroglioma with 1p/19qloss, brain .e 2128 to 2754 54 to 675       622/678
(91 %)
12 diff
(98.3 %id)
BM789120 Ascites, stomach .e 2138 to 2706 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BG831538 epithelioid carcinoma cell line, Pancreas .e 2146 to 2887 1 to 743       743/744
(99 %)
2 diff
(99.8 %id)
BX334898 Placenta Cot 25-normalized .e 2147 to 3180 1037 to 6       1032/1178
(87 %)
7 diff
(99.5 %id)
BG677751 skin, squamous cell carcinoma .e 2190 to 2895 1 to 712       712/881
(80 %)
19 diff
(97.9 %id)
BM712251 eye, lens .e 2195 to 2704 1 to 510   fully sequenced, Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 510/510
(100 %)
0 diff
(100 %id)
DB306769 caudate nucleus .e 2662 to 3210 550 to 1       550/550
(100 %)
1 diff
(99.9 %id)
BU737720 eye, lens .e 2674 to 3216 561 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 543/543
(100 %)
1 diff
(99.9 %id)
DB368562   .e 2691 to 3216 521 to 1       521/525
(99 %)
13 diff
(97.6 %id)
BU730553 eye, RPE and Choroid .e 2691 to 3222 550 to 19   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 532/532
(100 %)
1 diff
(99.9 %id)
AW731879 lung, small cell carcinoma .e 2736 to 3218 486 to 4       483/486
(99 %)
0 diff
(100 %id)
BU726369 eye, RPE and Choroid .e 2755 to 3219 479 to 15   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 465/465
(100 %)
1 diff
(99.8 %id)
DB362403   .e 2759 to 3216 458 to 1       458/461
(99 %)
5 diff
(99.0 %id)
DA184411 amygdala .f 1 to 529 2 to 531   tiling clone, capped   530/530
(100 %)
4 diff
(99.3 %id)
AK027608   .f 2 to 3193 1 to 3192 L63S P76S S428P S471G tiling clone, available from FLJ,   3192/3192
(100 %)
8 diff
(99.8 %id)
DA418575 thalamus .f 2 to 568 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
NM_001170718.1   .f 2 to 3265 1 to 3264 exact RefSeq, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 3264/3264
(100 %)
0 diff
(100 %id)
DA194514 amygdala .f 3 to 601 2 to 603   capped   602/602
(100 %)
4 diff
(99.4 %id)
DA435475 tongue, tumor tissue .f 3 to 566 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA451579 tongue, tumor tissue .f 3 to 423 2 to 422   capped   421/421
(100 %)
1 diff
(99.8 %id)
DA735188   .f 3 to 513 2 to 512   capped   511/511
(100 %)
2 diff
(99.7 %id)
DA754921   .f 3 to 539 2 to 538   capped   537/537
(100 %)
2 diff
(99.7 %id)
DA755045   .f 3 to 548 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA852673 placenta .f 3 to 558 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DB088208 testis .f 3 to 561 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
CN348299 embryonic stem cells, cell lines H1, H7, andH9 .f 8 to 617 1 to 610       610/610
(100 %)
3 diff
(99.6 %id)
AL521480 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 10 to 881 1 to 872       872/872
(100 %)
3 diff
(99.7 %id)
BQ940083 epidermoid carcinoma, cell line, lung .f 27 to 639 1 to 620       620/1168
(53 %)
30 diff
(97.5 %id)
BQ955137 epidermoid carcinoma, cell line, lung .f 27 to 804 1 to 781       781/887
(88 %)
6 diff
(99.4 %id)
BU553704 ovary, teratocarcinoma, cell line .f 27 to 759 1 to 738       738/958
(77 %)
23 diff
(97.6 %id)
DA188872 amygdala .f 29 to 334 2 to 307   capped   306/306
(100 %)
2 diff
(99.4 %id)
DA475927   .f 29 to 589 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA117653 cerebellum .f 31 to 485 2 to 458   capped   457/457
(100 %)
3 diff
(99.4 %id)
DA387627 thalamus .f 31 to 614 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
DA741608   .f 31 to 454 2 to 426   capped   425/425
(100 %)
2 diff
(99.6 %id)
DA806681 brain .f 31 to 592 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA841866 placenta .f 31 to 566 2 to 538   capped   537/537
(100 %)
3 diff
(99.5 %id)
DA854976 placenta .f 31 to 625 2 to 597   capped   596/596
(100 %)
2 diff
(99.7 %id)
DA854983 placenta .f 31 to 626 2 to 598   capped   597/597
(100 %)
2 diff
(99.7 %id)
BX374602 Neuroblastoma Cot 10-normalized .f 32 to 762 1 to 730       730/730
(100 %)
4 diff
(99.5 %id)
DA455796 tongue, tumor tissue .f 32 to 533 2 to 504   capped   503/503
(100 %)
3 diff
(99.5 %id)
BX332491 Neuroblastoma Cot 25-normalized .f 33 to 974 23 to 956       934/1037
(90 %)
21 diff
(98.0 %id)
AL535148 brain, fetal brain .f 33 to 877 23 to 866       844/866
(97 %)
7 diff
(99.2 %id)
BX355574 Placenta Cot 25-normalized .f 33 to 807 23 to 778       684/778
(87 %)
26 diff
(96.7 %id)
BX396822 Placenta Cot 25-normalized .f 33 to 968 23 to 957       935/957
(97 %)
11 diff
(98.9 %id)
CN348294 embryonic stem cells, cell lines H1, H7, andH9 .f 37 to 600 1 to 563       563/563
(100 %)
6 diff
(99.0 %id)
BX357182 Placenta Cot 25-normalized .f 37 to 969 24 to 949       926/949
(97 %)
19 diff
(98.0 %id)
BX421175 B cells (Ramos cell line) .f 40 to 1065 27 to 1044       1018/1051
(96 %)
24 diff
(97.8 %id)
DR157775 human embryonic stem cells differentiated toan early endodermal cell type .f 40 to 592 1 to 553       553/553
(100 %)
0 diff
(100 %id)
BI488566 brain .f 42 to 855 1 to 821       821/821
(100 %)
24 diff
(97.1 %id)
TI_45379116   .f 42 to 855 61 to 881       821/881
(93 %)
29 diff
(96.8 %id)
TI_44346255   .f 44 to 805 79 to 835       757/845
(89 %)
38 diff
(95.6 %id)
DA270881 caudate nucleus .f 45 to 590 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
CX867564 embryonic stem .f 45 to 773 1 to 729   tiling clone,   729/729
(100 %)
0 diff
(100 %id)
DA810539 brain .f 45 to 589 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
BM791808 stomach .f 45 to 679 1 to 635       635/635
(100 %)
1 diff
(99.9 %id)
DA120496 cerebellum .f 46 to 543 2 to 499   capped   498/498
(100 %)
1 diff
(99.8 %id)
DA416031 thalamus .f 46 to 600 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA739447   .f 46 to 552 2 to 508   capped   507/507
(100 %)
4 diff
(99.3 %id)
DA862426 placenta .f 46 to 609 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA888539   .f 46 to 589 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
DB075730 testis .f 46 to 589 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
DB155648 thymus .f 46 to 625 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
CO248282 Chondrosarcoma Lung Metastasis cell lines, lung .f 48 to 762 1 to 711       711/800
(88 %)
17 diff
(97.9 %id)
DA991526 synovial membrane tissue from rheumatioidarthritis .f 48 to 577 2 to 533   capped   532/532
(100 %)
3 diff
(99.5 %id)
CR747048 ovary (pool of 3) .f 49 to 555 1 to 507       507/507
(100 %)
1 diff
(99.9 %id)
DA474626   .f 49 to 282 2 to 235   capped   234/234
(100 %)
0 diff
(100 %id)
BM545006 ovary (pool of 3) .f 49 to 974 15 to 941       927/1124
(82 %)
21 diff
(98.2 %id)
BX394017 Neuroblastoma Cot 25-normalized .f 50 to 1043 34 to 1015       982/1015
(96 %)
26 diff
(97.5 %id)
CN348302 embryonic stem cells, cell lines H1, H7, andH9 .f 51 to 551 1 to 501       501/501
(100 %)
2 diff
(99.7 %id)
DA122409 cerebellum .f 53 to 510 2 to 460   capped   459/459
(100 %)
4 diff
(99.2 %id)
DA184153 amygdala .f 53 to 603 2 to 552   capped   551/551
(100 %)
3 diff
(99.5 %id)
DA855270 placenta .f 53 to 637 2 to 587   capped   586/586
(100 %)
3 diff
(99.5 %id)
CN348292 embryonic stem cells, cell lines H1, H7, andH9 .f 56 to 597 1 to 542       542/542
(100 %)
1 diff
(99.9 %id)
TI_57170181   .f 57 to 715 30 to 705       676/775
(87 %)
33 diff
(95.8 %id)
DA475658   .f 60 to 582 2 to 524   capped   523/523
(100 %)
1 diff
(99.9 %id)
BX343048   .f 62 to 974 22 to 936       915/1022
(89 %)
16 diff
(98.5 %id)
BI820892 pooled brain, lung, testis .f 62 to 722 1 to 694       651/934
(69 %)
30 diff
(96.8 %id)
TI_57197078   .f 62 to 722 60 to 753       651/993
(65 %)
33 diff
(96.7 %id)
TI_57202716   .f 62 to 928 58 to 922       863/923
(93 %)
34 diff
(96.4 %id)
CN348289 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 65 to 538 1 to 474       474/474
(100 %)
1 diff
(99.8 %id)
BI825134 brain, medulla .f 65 to 715 1 to 669       669/739
(90 %)
45 diff
(94.0 %id)
BU931284 ovary, teratocarcinoma, cell line .f 66 to 621 201 to 762       562/888
(63 %)
25 diff
(97.2 %id)
BI823536 pooled brain, lung, testis .f 67 to 928 1 to 860       858/861
(99 %)
29 diff
(96.7 %id)
BX353472 Neuroblastoma Cot 25-normalized .f 68 to 942 1 to 874       874/874
(100 %)
2 diff
(99.8 %id)
CN348293 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 79 to 405 1 to 327       327/327
(100 %)
4 diff
(98.8 %id)
CN348300 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 99 to 663 1 to 565       565/565
(100 %)
2 diff
(99.7 %id)
AI796345 2 pooled tumors (clear cell type), Kidney .f 106 to 186 81 to 1       81/81
(100 %)
0 diff
(100 %id)
DB100753 testis .f 126 to 697 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BX332490 Neuroblastoma Cot 25-normalized .f 2183 to 3224 1040 to 1       1040/1046
(99 %)
7 diff
(99.4 %id)
BX396821 Placenta Cot 25-normalized .f 2265 to 3230 970 to 1       970/970
(100 %)
19 diff
(98.1 %id)
BX343047   .f 2269 to 3227 958 to 1       958/1043
(91 %)
6 diff
(99.5 %id)
BM826658 Ascites, stomach .f 2293 to 2801 1 to 509       509/509
(100 %)
0 diff
(100 %id)
BM798009 Ascites, stomach .f 2299 to 2663 1 to 365       365/365
(100 %)
0 diff
(100 %id)
BM717568 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 2304 to 2700 1 to 397   fully sequenced, Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 397/397
(100 %)
4 diff
(99.0 %id)
AL561995 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 2330 to 3241 910 to 1       910/910
(100 %)
21 diff
(97.7 %id)
BM724817 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 2331 to 2927 1 to 594   fully sequenced, Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 594/594
(100 %)
1 diff
(99.9 %id)
CN401184 embryonic stem cells, DMSO-treated H9 cellline .f 2335 to 3009 1 to 675       675/675
(100 %)
1 diff
(99.9 %id)
AL535147 brain, fetal brain .f 2336 to 3232 898 to 1       898/898
(100 %)
15 diff
(98.4 %id)
TI_154135014   .f 2342 to 3262 986 to 78   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 909/975
(93 %)
37 diff
(96.3 %id)
BX357181 Placenta Cot 25-normalized .f 2366 to 3206 835 to 1       835/852
(98 %)
23 diff
(97.4 %id)
TI_149297055   .f 2374 to 3259 947 to 78   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 870/971
(89 %)
59 diff
(94.0 %id)
BU781612 insulinoma, Pancreas .f 2385 to 2738 1 to 354   fully sequenced, Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 354/354
(100 %)
5 diff
(98.6 %id)
BM471929 melanotic melanoma, skin .f 2398 to 3064 13 to 681   tiling clone,   669/1055
(63 %)
4 diff
(99.7 %id)
TI_159713317   .f 2411 to 3259 921 to 76   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 846/972
(87 %)
43 diff
(95.6 %id)
BX372628 Neuroblastoma Cot 25-normalized .f 2422 to 3257 845 to 1       845/924
(91 %)
65 diff
(93.0 %id)
BX413945 B cells (Ramos cell line) .f 2449 to 3258 819 to 1       819/920
(89 %)
50 diff
(94.6 %id)
AW001536 colon, colonic mucosa from 3 patients with Crohn'sdisease .f 2455 to 3260 794 to 1       794/796
(99 %)
30 diff
(96.3 %id)
TI_227715565   .f 2462 to 3259 879 to 90   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 790/964
(81 %)
10 diff
(99.0 %id)
BU174680 ductal carcinoma, cell line, Pancreas .f 2463 to 3128 1 to 676       676/898
(75 %)
23 diff
(97.5 %id)
BQ877848 ductal carcinoma, cell line, Pancreas .f 2463 to 3154 1 to 698       698/829
(84 %)
18 diff
(97.9 %id)
BU538302 adenocarcinoma, cell line, breast .f 2463 to 3253 1 to 791   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 791/791
(100 %)
3 diff
(99.7 %id)
BM717138 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 2483 to 3199 1 to 717       717/724
(99 %)
9 diff
(98.8 %id)
CN401182 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 2489 to 3096 1 to 608       608/608
(100 %)
1 diff
(99.9 %id)
AI191323 lung .f 2495 to 3260 768 to 1       768/768
(100 %)
25 diff
(96.8 %id)
CA418835 Chondrosarcoma Grade II, Left Pelvis .f 2510 to 3259 768 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 750/750
(100 %)
0 diff
(100 %id)
BG029625 breast, mammary adenocarcinoma, cell line .f 2511 to 3253 1 to 752       752/1068
(70 %)
16 diff
(98.6 %id)
BM825466 Ascites, stomach .f 2516 to 3069 1 to 554       554/554
(100 %)
0 diff
(100 %id)
TI_151715403   .f 2519 to 3259 865 to 125   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 741/745
(99 %)
0 diff
(100 %id)
CD370357 Alveolar Macrophage, lung .f 2525 to 3259 754 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 736/736
(100 %)
5 diff
(99.4 %id)
BG260839 bladder, transitional cell papilloma, cell line .f 2531 to 3252 1 to 721       721/742
(97 %)
9 diff
(98.8 %id)
BM910846 astrocytoma grade IV, cell line, brain .f 2534 to 3259 1 to 728   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 728/729
(99 %)
9 diff
(98.8 %id)
BM792707 Ascites, stomach .f 2534 to 3061 1 to 528       528/528
(100 %)
0 diff
(100 %id)
TI_159714910   .f 2548 to 3259 790 to 79   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 712/996
(71 %)
2 diff
(99.8 %id)
CN401183 embryonic stem cells, DMSO-treated H9 cellline .f 2561 to 3208 1 to 649       649/649
(100 %)
1 diff
(99.9 %id)
BQ771939 Chondrosarcoma Grade II, Left Pelvis .f 2562 to 3259 716 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 698/698
(100 %)
0 diff
(100 %id)
BU618506 Cell Line, Chondrosarcoma .f 2562 to 3259 716 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 698/698
(100 %)
2 diff
(99.8 %id)
BM680418 eye, fetal eye .f 2563 to 3253 709 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 691/691
(100 %)
0 diff
(100 %id)
TI_151706639   .f 2566 to 3259 768 to 75   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 694/959
(72 %)
9 diff
(99.1 %id)
AI378600 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 2567 to 3259 707 to 17   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 691/691
(100 %)
12 diff
(98.3 %id)
AI963597 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 2568 to 3261 694 to 2       693/695
(99 %)
0 diff
(100 %id)
BQ222109 epithelioid carcinoma, Pancreas .f 2571 to 3264 1 to 694   tiling clone, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 694/696
(99 %)
2 diff
(99.8 %id)
TI_149303040   .f 2573 to 3259 772 to 86   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 687/953
(72 %)
0 diff
(100 %id)
BM981125 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 2573 to 3259 705 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 687/692
(99 %)
0 diff
(100 %id)
BM694512 eye, RPE and Choroid .f 2573 to 2936 1 to 364       364/364
(100 %)
0 diff
(100 %id)
BM700048 eye, lens .f 2573 to 3031 1 to 459   fully sequenced, Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 459/459
(100 %)
0 diff
(100 %id)
CR622696 Placenta Cot 25-normalized .f 2581 to 3261 1 to 681       681/681
(100 %)
0 diff
(100 %id)
BX334660 Placenta Cot 25-normalized .f 2581 to 3261 1 to 679   fully sequenced,   679/679
(100 %)
2 diff
(99.8 %id)
BU627412 Bone, Enchondroma cell line .f 2616 to 3259 662 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 644/644
(100 %)
3 diff
(99.6 %id)
BU621927 Cell Line, Chondrosarcoma .f 2628 to 3259 650 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 632/632
(100 %)
2 diff
(99.7 %id)
BQ002476 Chondrosarcoma, Left Pelvis .f 2637 to 3259 640 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 622/622
(100 %)
4 diff
(99.4 %id)
CD367951 Alveolar Macrophage, lung .f 2637 to 3259 642 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 624/624
(100 %)
2 diff
(99.7 %id)
TI_149289064   .f 2641 to 3259 708 to 90   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 619/980
(63 %)
4 diff
(99.6 %id)
BM982188 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 2641 to 3259 637 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 619/619
(100 %)
0 diff
(100 %id)
CN478831 Human Lung Epithelial cells, lung .f 2641 to 3259 637 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 619/619
(100 %)
1 diff
(99.9 %id)
BU632649 cell lines, Chondrosarcoma .f 2641 to 3259 637 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 619/619
(100 %)
2 diff
(99.7 %id)
CD366691 Alveolar Macrophage, lung .f 2641 to 3259 637 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 619/619
(100 %)
1 diff
(99.9 %id)
BM720377 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 2642 to 3074 1 to 433   fully sequenced, Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 433/433
(100 %)
0 diff
(100 %id)
BU618879 Cell Line, Chondrosarcoma .f 2642 to 3259 636 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 618/618
(100 %)
5 diff
(99.2 %id)
CA422785 cell lines, Chondrosarcoma .f 2642 to 3259 635 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 617/617
(100 %)
3 diff
(99.6 %id)
BQ008556 Chondrosarcoma, Left Pubic Bone .f 2654 to 3259 624 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 606/606
(100 %)
1 diff
(99.9 %id)
CX867484 embryonic stem .f 2654 to 3259 636 to 31       606/636
(95 %)
0 diff
(100 %id)
CB322051 Human Lung Epithelial cells, lung .f 2656 to 3259 622 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 604/604
(100 %)
1 diff
(99.9 %id)
DR760073 embryonic stem .f 2660 to 3261 1 to 602       602/605
(99 %)
5 diff
(99.2 %id)
BU620524 cell lines, Chondrosarcoma .f 2668 to 3259 610 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 592/592
(100 %)
2 diff
(99.7 %id)
BM674838 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 2670 to 3193 544 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 526/526
(100 %)
2 diff
(99.7 %id)
BQ439177 epithelioid carcinoma, Pancreas .f 2673 to 3259 625 to 39   AAA Submitted on the opposite strand 587/835
(70 %)
3 diff
(99.7 %id)
BQ447600 Knee, Osteoarthritic Cartilage .f 2675 to 3259 603 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 585/585
(100 %)
0 diff
(100 %id)
BQ574381 Chondrosarcoma Grade II, Left Pelvis .f 2677 to 3259 601 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 583/583
(100 %)
0 diff
(100 %id)
BX372535 Neuroblastoma Cot 10-normalized .f 2679 to 3244 564 to 1       564/706
(79 %)
17 diff
(97.6 %id)
DB367392   .f 2679 to 3193 515 to 1       515/518
(99 %)
12 diff
(97.7 %id)
AW516899 cervix .f 2693 to 3255 563 to 1       563/563
(100 %)
0 diff
(100 %id)
CB853295 Human Lung Epithelial cells, lung .f 2701 to 3259 577 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 559/559
(100 %)
0 diff
(100 %id)
CB851996 Human Lung Epithelial cells, lung .f 2704 to 3259 574 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 556/556
(100 %)
0 diff
(100 %id)
BU786754 insulinoma, Pancreas .f 2708 to 3259 573 to 22   fully sequenced, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 552/552
(100 %)
0 diff
(100 %id)
CF529919 placenta .f 2788 to 3259 490 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 472/472
(100 %)
0 diff
(100 %id)
AI983805 colon, colonic mucosa from 3 patients with Crohn'sdisease .f 2820 to 3259 456 to 17   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 440/440
(100 %)
0 diff
(100 %id)
AI369230 anaplastic oligodendroglioma, brain .f 2829 to 3259 443 to 13   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 431/431
(100 %)
0 diff
(100 %id)
AW301077 colon, moderately differentiated adenocarcinoma .f 2829 to 3259 457 to 27   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 431/431
(100 %)
0 diff
(100 %id)
AI493518 anaplastic oligodendroglioma, brain .f 2833 to 3262 430 to 1   tiling clone,   430/430
(100 %)
0 diff
(100 %id)
CF529831 placenta .f 2842 to 3259 436 to 19   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 418/418
(100 %)
0 diff
(100 %id)
AA364512 pineal body .f 2868 to 3056 1 to 189       189/189
(100 %)
0 diff
(100 %id)
BM468717 leiomyosarcoma, uterus .f 2880 to 3259 1 to 380   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 380/380
(100 %)
0 diff
(100 %id)
BU741453 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 2897 to 3259 381 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 363/363
(100 %)
1 diff
(99.8 %id)
BX334659 Placenta Cot 25-normalized .f 2906 to 3231 331 to 1   fully sequenced,   331/331
(100 %)
4 diff
(98.8 %id)
BX334266 Placenta Cot 25-normalized .f 2956 to 3203 252 to 1       252/252
(100 %)
6 diff
(97.7 %id)
BU737850 eye, lens .f 3001 to 3259 277 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 259/259
(100 %)
1 diff
(99.7 %id)
BM678717 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 3044 to 3262 234 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 219/219
(100 %)
1 diff
(99.6 %id)
T35098 placenta .f 3054 to 3259 206 to 1       206/206
(100 %)
0 diff
(100 %id)
AW166472 cervix .f 3081 to 3259 179 to 1       179/179
(100 %)
0 diff
(100 %id)
AI055829 anaplastic oligodendroglioma, brain .f 3166 to 3259 117 to 24   AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 94/94
(100 %)
0 diff
(100 %id)
DC310094 cerebellum .g 1 to 543 1 to 543   tiling clone,   543/543
(100 %)
1 diff
(99.9 %id)
NM_001170719.1   .g 1 to 3354 1 to 3354 exact RefSeq, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 3354/3354
(100 %)
0 diff
(100 %id)
AK294513 amygdala .g 85 to 2932 1 to 2848 P74S tiling clone,   2848/2848
(100 %)
5 diff
(99.9 %id)
DC318076 amygdala .g 85 to 671 1 to 587       587/587
(100 %)
3 diff
(99.5 %id)
DC338400 subthalamic nucleus .g 98 to 652 1 to 555       555/555
(100 %)
3 diff
(99.5 %id)
DC344417 thalamus .g 99 to 573 1 to 477       477/477
(100 %)
16 diff
(96.7 %id)
DC325790 caudate nucleus .g 174 to 697 1 to 524       524/524
(100 %)
2 diff
(99.7 %id)
DC315868 amygdala .g 176 to 745 1 to 570       570/570
(100 %)
2 diff
(99.7 %id)
DC316218 amygdala .g 176 to 732 1 to 558       558/558
(100 %)
3 diff
(99.5 %id)
DC328245 corpus callosum .g 176 to 723 1 to 548       548/548
(100 %)
2 diff
(99.7 %id)
DC331630 hippocampus .g 176 to 733 1 to 558       558/558
(100 %)
2 diff
(99.7 %id)
AK124526 cerebellum .h 1 to 4658 2 to 4659 P47S tiling clone, available from FLJ,   4659/4659
(100 %)
6 diff
(99.9 %id)
DA094328 cerebellum .h 1 to 459 2 to 461   capped   460/460
(100 %)
2 diff
(99.6 %id)
DA096864 cerebellum .h 411 to 975 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BQ370689 placenta_normal .h 520 to 1060 558 to 15       544/558
(97 %)
0 diff
(100 %id)
DA097519 cerebellum .h 551 to 1108 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA096264 cerebellum .h 680 to 1222 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
BF814923 colon_ins .h 719 to 1047 331 to 3     Submitted on the opposite strand 329/332
(99 %)
0 diff
(100 %id)
AW291070   .h 798 to 1344 559 to 13   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 547/559
(97 %)
0 diff
(100 %id)
BF869656 lung_tumor .h 978 to 1415 438 to 1     Submitted on the opposite strand 438/438
(100 %)
1 diff
(99.8 %id)
BF945829 nervous_normal .h 1065 to 1209 7 to 151       145/153
(94 %)
10 diff
(93.5 %id)
DB298551 cerebellum .h 4090 to 4658 569 to 1       569/569
(100 %)
1 diff
(99.9 %id)
AK302617 testis .i 1 to 2894 1 to 2894 Q552R tiling clone,   2894/2894
(100 %)
3 diff
(99.9 %id)
NM_001170720.1   .i 1 to 2925 1 to 2925 exact RefSeq, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 2925/2925
(100 %)
0 diff
(100 %id)
DC401440 testis .i 1 to 491 1 to 491       491/491
(100 %)
0 diff
(100 %id)
DA122950 cerebellum .j 1 to 556 2 to 557   tiling clone, capped   556/556
(100 %)
1 diff
(99.9 %id)
CX867752 embryonic stem .j 354 to 1033 1 to 680   tiling clone,   680/680
(100 %)
1 diff
(99.9 %id)
NM_001170721.1   .j 354 to 3805 1 to 3452 exact RefSeq, AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base) 3452/3452
(100 %)
0 diff
(100 %id)
DA216382 brain .j 472 to 960 2 to 490   capped   489/489
(100 %)
1 diff
(99.8 %id)
DA333978 hippocampus .j 549 to 1120 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA121434 cerebellum .j 669 to 1168 2 to 501   capped   500/500
(100 %)
2 diff
(99.6 %id)
AK124844 hippocampus .j 776 to 3799 1 to 3024 exact tiling clone, available from FLJ,   3024/3024
(100 %)
4 diff
(99.9 %id)
DA295793 hippocampus .j 777 to 1347 2 to 574   capped   573/578
(99 %)
4 diff
(99.4 %id)
DA299863 hippocampus .j 1085 to 1638 17 to 570   capped   554/554
(100 %)
1 diff
(99.9 %id)
BJ996738 hepatoblastoma .j 1086 to 1552 1 to 467       467/467
(100 %)
0 diff
(100 %id)
BG912410 anaplastic oligodendroglioma with 1p/19qloss, brain .j 1103 to 1703 1 to 606       606/606
(100 %)
16 diff
(97.4 %id)
CX867672 embryonic stem .j 3193 to 3801 631 to 24   tiling clone,   608/631
(96 %)
0 diff
(100 %id)
DB307817 hippocampus .j 3270 to 3799 530 to 1       530/533
(99 %)
2 diff
(99.7 %id)
AL044431 testis .k-u 1 to 311 1 to 306   tiling clone,   306/306
(100 %)
8 diff
(97.4 %id)
AK127004 brain .k-u 1387 to 5470 1 to 4084   tiling clone, available from FLJ,   4084/4084
(100 %)
7 diff
(99.9 %id)
DA228817 brain .k-u 1388 to 1929 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
CN294986 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k-u 2722 to 3228 1 to 507       507/507
(100 %)
2 diff
(99.7 %id)
BM474877 duodenal adenocarcinoma, cell line, small intestine .k-u 3120 to 3916 1 to 802   tiling clone,   802/1040
(77 %)
20 diff
(98.1 %id)
AK022238 mammary gland .k-u 3506 to 5470 1 to 1965   tiling clone, available from FLJ,   1965/1965
(100 %)
2 diff
(99.9 %id)
AU121673 mammary gland .k-u 3507 to 4209 2 to 708   capped   707/717
(98 %)
8 diff
(98.9 %id)
BQ707585 Spleen .k-u 3540 to 4337 1 to 812       812/909
(89 %)
22 diff
(97.6 %id)
BQ707204 Spleen .k-u 3540 to 4436 1 to 910       910/936
(97 %)
39 diff
(95.9 %id)
DA355125 subthalamic nucleus .k-u 3550 to 4089 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
BF325856 amnion_normal .k-u 4372 to 4767 402 to 7       396/402
(98 %)
0 diff
(100 %id)
BY795274 eye .k-u 4435 to 5041 1 to 607       607/607
(100 %)
0 diff
(100 %id)
BF869714 lung_tumor .k-u 4726 to 4992 267 to 1     Submitted on the opposite strand 267/267
(100 %)
2 diff
(99.3 %id)
AU147442 mammary gland .k-u 4906 to 5470 565 to 1       565/567
(99 %)
19 diff
(96.7 %id)
AA922330 squamous cell carcinoma from base of tongue, tongue .k-u 4991 to 5484 495 to 1   tiling clone,   495/495
(100 %)
5 diff
(99.0 %id)
AL044432 testis .k-u 5063 to 5482 419 to 1       419/419
(100 %)
4 diff
(99.1 %id)
DA081520 cerebellum .l 1 to 546 2 to 547   tiling clone, capped   546/546
(100 %)
1 diff
(99.9 %id)
DR762583 embryonic stem .l 476 to 1189 1 to 714   tiling clone,   714/714
(100 %)
0 diff
(100 %id)
DA660133   .m 1 to 576 2 to 577   tiling clone, capped   576/577
(99 %)
3 diff
(99.5 %id)
CV376614 uterus_tumor .m 401 to 806 54 to 457   tiling clone,   404/457
(88 %)
6 diff
(98.7 %id)
CV413478 placenta_normal .m 666 to 1124 1 to 458   tiling clone,   458/458
(100 %)
17 diff
(96.3 %id)
AK125719 testis .m 731 to 3422 1 to 2692 I168M tiling clone, available from FLJ,   2692/2692
(100 %)
1 diff
(100.0 %id)
DB019839 testis .m 732 to 1267 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
BI036120 nervous_tumor .m 741 to 1042 302 to 1       302/309
(97 %)
1 diff
(99.7 %id)
BI036137 nervous_tumor .m 741 to 1042 302 to 1       302/309
(97 %)
1 diff
(99.7 %id)
BI040172 nervous_tumor .m 741 to 1042 302 to 1       302/309
(97 %)
1 diff
(99.7 %id)
BI040177 nervous_tumor .m 741 to 1042 306 to 5       302/313
(96 %)
0 diff
(100 %id)
DB335740 testis .m 2865 to 3422 559 to 1       559/559
(100 %)
1 diff
(99.9 %id)
DB321884   .m 3244 to 3416 174 to 1       174/174
(100 %)
2 diff
(98.9 %id)
AW818710 stomach .n 1 to 429 1 to 423 T8P F9S S10R K11S Q12R ... tiling clone,   423/423
(100 %)
10 diff
(97.7 %id)
DA106933 cerebellum .o-u 1 to 588 2 to 591 W132L L133V C134V G135R tiling clone, capped   590/590
(100 %)
2 diff
(99.7 %id)
DA092617 cerebellum .o-u 45 to 538 2 to 495 R118X tiling clone, capped   494/494
(100 %)
1 diff
(99.8 %id)
DA786137 brain .p 1 to 557 2 to 558 exact tiling clone, capped   557/557
(100 %)
4 diff
(99.3 %id)
DA857903 placenta .p 148 to 716 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
BP287647 lung .p 174 to 753 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
DB222577 trachea .p 212 to 790 2 to 581   tiling clone, capped   580/580
(100 %)
1 diff
(99.9 %id)
DA103073 cerebellum .q 1 to 551 2 to 553 R4E P5A P6A S7Q R8P ... tiling clone, capped   552/552
(100 %)
1 diff
(99.9 %id)
DA111123 cerebellum .r 1 to 593 2 to 594 P47S tiling clone, capped   593/593
(100 %)
1 diff
(99.9 %id)
DA226497 brain .s 1 to 576 2 to 577 exact tiling clone, capped   576/580
(99 %)
2 diff
(99.7 %id)
DA249687 brain .t 1 to 575 2 to 576 exact tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
DA308602 hippocampus .u 1 to 557 2 to 558 P47S tiling clone, capped   557/557
(100 %)
1 diff
(99.9 %id)
DA628456 Kidney .va 1 to 555 2 to 556 P47S tiling clone, capped   555/555
(100 %)
1 diff
(99.9 %id)
AA813723   Gene BCAR1, variant not shown       AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base)    
BI053671 placenta_normal Gene BCAR1, variant not shown              
BI053673 placenta_normal Gene BCAR1, variant not shown              
DB299469 cerebellum Gene BCAR1, variant not shown              
DA105510 cerebellum Gene BCAR1, variant not shown       capped      
H05478 whole brain Gene BCAR1, variant not shown       AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base)    
H43108 brain Gene BCAR1, variant not shown              
H43174 brain Gene BCAR1, variant not shown              
AA064899   Gene BCAR1, variant not shown              
BF315803 brain, neuroblastoma Gene BCAR1, variant not shown              
BQ016861 lung, Lung Focal Fibrosis Gene BCAR1, variant not shown       AAA Possibly primed on the genome, locally A rich (29/29 A in genome downstream of last aligned base)    
292 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l, .m, .n, .o-u, .p, .q, .r, .s, .t, .u, .va Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI